Biomarkers of Alzheimer's disease
- 28 October 2008
- journal article
- review article
- Published by Elsevier in Neurobiology of Disease
- Vol. 35 (2) , 128-140
- https://doi.org/10.1016/j.nbd.2008.10.003
Abstract
No abstract availableKeywords
This publication has 287 references indexed in Scilit:
- Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studiesPublished by Elsevier ,2007
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- CSF markers related to pathogenetic mechanisms in Alzheimer's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer’s disease patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2001
- Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementiaNeurobiology of Aging, 1995
- Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changesNeuroscience Letters, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Detection of amyloid beta protein precursor immunoreactivity in normal and Alzheimer's disease cerebrospinal fluidLife Sciences, 1989
- Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: Immunohistochemical and biochemical characterizationBiochemical and Biophysical Research Communications, 1989
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985